Drug intelligence / Profile preview

Brucella abortus S19 Delta Pe28 vaccine

Development stage
Preclinical
Lead developer
Indian Veterinary Research Institute
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intraconjunctival, Intramuscular
01

Overview

The **Brucella abortus S19 Delta Pe28 vaccine** is a live attenuated bacterial vaccine derived from the standard Brucella abortus strain S19, with a targeted deletion in the pe28 gene to enhance safety and distinguishability from wild-type strains. As a modified version of the S19 vaccine, it induces protective immunity against bovine brucellosis by eliciting humoral and cellular responses specific to Brucella antigens while minimizing persistence and virulence-associated effects of the parental strain. Primarily indicated for immunization of cattle to prevent abortion and infection caused by B. abortus, it leverages the attenuated phenotype of S19—due to defects in erythritol metabolism and other virulence factors—with the pe28 deletion likely further reducing regulatory gene-mediated persistence.

Beyond the preview

Go deeper on Brucella abortus S19 Delta Pe28 vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brucella abortus S19 Delta Pe28 vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call